TY - JOUR
T1 - Cytotoxicity of cis-platinum(II) conjugate models. The effect of chelating arms and leaving groups on cytotoxicity
T2 - A quantitative structure-activity relationship approach
AU - Monti, Elena
AU - Gariboldi, Marzia
AU - Maiocchi, Alessandro
AU - Marengo, Emilio
AU - Cassino, Claudio
AU - Gabano, Elisabetta
AU - Osella, Domenico
PY - 2005/2/10
Y1 - 2005/2/10
N2 - Thirteen newly synthesized or resynthesized diamine-platinum(II) complexes were character-ized, and their cytotoxic activities (IC50) were tested on parental and resistant ovarian cancer cell lines. They represent models of conjugates between biologically active vectors and cytotoxic Pt II moieties within the "drug targeting and delivery strategy". Three drugs, routinely employed in the clinical treatment of cancer, namely, cisplatin, carboplatin, and oxaliplatin, were also included in the study as controls. The quantitative structure-activity relationship approach provides simple regression models able to predict log(1/IC50) of diamine-platinum(II) complexes on both parental and resistant ovarian cancer cell lines. The 16 complexes were characterized using 197 molecular descriptors, after which the best regression models relating a subset of these descriptors to the log(1/IC50) in the two cancer cell lines were calculated. Models with four variables proved to be endowed with very good predictive ability Q2LMO-50% ≥ 85.6%, making it possible to discard 50% of the molecules from the test set following for cross-validation procedure. A four-variable regression model also proved effective in predicting the resistance index RI, Q2LMO-50% = 84.4%.
AB - Thirteen newly synthesized or resynthesized diamine-platinum(II) complexes were character-ized, and their cytotoxic activities (IC50) were tested on parental and resistant ovarian cancer cell lines. They represent models of conjugates between biologically active vectors and cytotoxic Pt II moieties within the "drug targeting and delivery strategy". Three drugs, routinely employed in the clinical treatment of cancer, namely, cisplatin, carboplatin, and oxaliplatin, were also included in the study as controls. The quantitative structure-activity relationship approach provides simple regression models able to predict log(1/IC50) of diamine-platinum(II) complexes on both parental and resistant ovarian cancer cell lines. The 16 complexes were characterized using 197 molecular descriptors, after which the best regression models relating a subset of these descriptors to the log(1/IC50) in the two cancer cell lines were calculated. Models with four variables proved to be endowed with very good predictive ability Q2LMO-50% ≥ 85.6%, making it possible to discard 50% of the molecules from the test set following for cross-validation procedure. A four-variable regression model also proved effective in predicting the resistance index RI, Q2LMO-50% = 84.4%.
UR - http://www.scopus.com/inward/record.url?scp=13444310481&partnerID=8YFLogxK
U2 - 10.1021/jm049508t
DO - 10.1021/jm049508t
M3 - Article
SN - 0022-2623
VL - 48
SP - 857
EP - 866
JO - Journal of Medicinal Chemistry
JF - Journal of Medicinal Chemistry
IS - 3
ER -